Schering-Plough Overview

  • Year Founded
  • 1971

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 100,000

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 4

Schering-Plough General Information

Description

Developer of pharmaceuticals drugs based in Kenilworth, New Jersey. The company engages in the discovery, development and marketing of pharmaceutical products for the human health as well as animal health sector.

Contact Information

Formerly Known As
Plough Inc., Schering AG
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2000 Galloping Hill Road
  • Kenilworth, NJ 07033
  • United States
Primary Industry
Pharmaceuticals
Acquirer
Corporate Office
  • 2000 Galloping Hill Road
  • Kenilworth, NJ 07033
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Schering-Plough Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Schering-Plough‘s full profile, request access.

Request a free trial

Schering-Plough Patents

Schering-Plough Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-428333-B2 Method forthe preparation of 6-ketosteroids from 20-formyl-6-ketosteroids Inactive 04-Jan-1967
AU-1608567-A Method forthe preparation of 6-ketosteroids from 20-formyl-6-ketosteroids Inactive 04-Jan-1967
AU-290249-B2 1 new steroids ofthe pregnane series and processes for their manufacture Inactive 09-Feb-1965
AU-5487765-A 1 new steroids ofthe pregnane series and processes for their manufacture Inactive 09-Feb-1965
AU-409347-B2 Improvements in or relating lto soil treatment Inactive 03-Feb-1965
To view Schering-Plough’s complete patent history, request access »

Schering-Plough Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Schering-Plough Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Schering-Plough‘s full profile, request access.

Request a free trial

Schering-Plough Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Organon BioSciences 19-Nov-2007 0000000000 0000 Pharmaceuticals 0000 0000
NeoGenesis Pharmaceuticals 21-Feb-2005 0000000000 Pharmaceuticals 0000 0000
MAP Medical Technologies 15-Jul-2002 0000000000 Pharmaceuticals
Fulford India 01-Jan-1968 Merger/Acquisition Pharmaceuticals
To view Schering-Plough’s complete acquisitions history, request access »

Schering-Plough Subsidiaries (1)

Company Name Industry Location Founded
NeoGenesis Pharmaceuticals Pharmaceuticals San Diego, CA 0000
To view Schering-Plough’s complete subsidiaries history, request access »

Schering-Plough ESG

Risk Overview

Risk Rating

Updated May, 24, 2022

24.36 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,638

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 1,008

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 473

Rank

0.00

Percentile

To view Schering-Plough’s complete esg history, request access »

Schering-Plough FAQs

  • When was Schering-Plough founded?

    Schering-Plough was founded in 1971.

  • Where is Schering-Plough headquartered?

    Schering-Plough is headquartered in Kenilworth, NJ.

  • What is the size of Schering-Plough?

    Schering-Plough has 100,000 total employees.

  • What industry is Schering-Plough in?

    Schering-Plough’s primary industry is Pharmaceuticals.

  • Is Schering-Plough a private or public company?

    Schering-Plough is a Private company.

  • What is the current valuation of Schering-Plough?

    The current valuation of Schering-Plough is 000.00.

  • What is Schering-Plough’s current revenue?

    The current revenue for Schering-Plough is 000000.

  • Who are Schering-Plough’s investors?

    BofA Securities has invested in Schering-Plough.

  • When was Schering-Plough acquired?

    Schering-Plough was acquired on 03-Nov-2009.

  • Who acquired Schering-Plough?

    Schering-Plough was acquired by Merck & Co..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »